National Health Investors (FRA:WX6) Short-Term Debt: €380.2 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:WX6 National Health Investors Inc FRA:WX6
79 GF Score
Price €63.00
GF Value €72.82
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is National Health Investors Short-Term Debt?

National Health Investors FRA:WX6 79 Short-Term Debt is €380.2 Mil as of Jun. 2026. GuruFocus rates FRA:WX6 with a GF Score™ of 79/100 and a GF Value™ of €72.82 (Modestly Undervalued). The stock has 3 warning signs investors should review.

National Health Investors's Short-Term Debt for the quarter that ended in Jun. 2026 was €380.2 Mil.

National Health Investors's quarterly Short-Term Debt increased from Dec. 2025 (€174.2 Mil) to Mar. 2026 (€267.3 Mil) and increased from Mar. 2026 (€267.3 Mil) to Jun. 2026 (€380.2 Mil).

National Health Investors's annual Short-Term Debt increased from Dec. 2023 (€224.7 Mil) to Dec. 2024 (€316.3 Mil) but then declined from Dec. 2024 (€316.3 Mil) to Dec. 2025 (€174.2 Mil).

National Health Investors Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

National Health Investors Short-Term Debt Related Terms

National Health Investors Short-Term Debt Historical Data

* Premium members only.

The historical data trend for National Health Investors's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

National Health Investors Short-Term Debt Chart

National Health Investors Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 39.65 224.67 316.30 174.22

National Health Investors Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 327.73 85.20 174.22 267.29 380.18
FRA:WX6
79GF Score
National Health Investors Inc FRA:WX6
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of €380.2 Mil mean?
National Health Investors (FRA:WX6) has a Short-Term Debt of €380.2 Mil as of Jun. 2026.
Is National Health Investors' Short-Term Debt too high?
National Health Investors' current Short-Term Debt is €380.2 Mil. Overall, National Health Investors has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does National Health Investors' Short-Term Debt compare to MPT and DHC?
National Health Investors' Short-Term Debt of €380.2 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a REITs company?
A good Short-Term Debt depends on the REITs industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. National Health Investors's current Short-Term Debt is €380.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Health Investors stock overvalued right now?
Based on GuruFocus' analysis, National Health Investors (FRA:WX6) is currently considered Modestly Undervalued. The stock's GF Value™ is €72.82, compared to a current price of €63.00 — trading 13.5% below its estimated fair value. The current Short-Term Debt is €380.2 Mil. National Health Investors' overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For National Health Investors (FRA:WX6), the current Short-Term Debt is €380.2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is National Health Investors (FRA:WX6) Overvalued in 2026?

Based on GuruFocus' analysis, National Health Investors stock appears to be undervalued. The current stock price of €63.00 is trading 13.5% below its estimated GF Value™ of €72.82. GuruFocus considers National Health Investors to be Modestly Undervalued.

Key valuation signals for FRA:WX6:

  • Short-Term Debt: €380.2 Mil
  • GF Value™: €72.82 vs. price of €63.00 (13.5% below fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the FRA:WX6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

National Health Investors Business Description

Industry Real EstateREITs
Other Exchanges NHI:USA
Address 222 Robert Rose Drive, Murfreesboro, TN, USA, 37129
National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.
79GF Score

Get the complete analysis for FRA:WX6

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€63.00
Price
€72.82
GF Value